Natural killer cell activity in multiple sclerosis patients treated with recombinant interferon-α2
- 1 November 1985
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 37 (2) , 236-244
- https://doi.org/10.1016/0090-1229(85)90155-2
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Systemic alpha‐interferon therapy of multiple sclerosisNeurology, 1984
- Effect of Recombinant Alpha Interferon on NK and ADCC Function in Lung Cancer Patients: Results from a Phase II TrialJournal of Interferon Research, 1984
- Decreased Interferon Synthesis and Responsiveness to Interferon by Leukocytes from Multiple Sclerosis Patients Given Natural Alpha InterferonJournal of Interferon Research, 1984
- Natural killer cells activity in patients with multiple sclerosis given α interferonAnnals of Neurology, 1983
- Abnormal regulation of IgG production in multiple sclerosisNeurology, 1982
- Intrathecal Interferon Reduces Exacerbations of Multiple SclerosisScience, 1981
- Interferon‐Induced NK Augmentation in HumansScandinavian Journal of Immunology, 1981
- Interferon and spontaneous cytotoxicity in man. V. Enhancement of spontaneous cytotoxicity in patients receiving human leukocyte interferonInternational Journal of Cancer, 1980
- Suppressor cell function in multiple sclerosis: Correlation with clinical disease activityAnnals of Neurology, 1979
- Multiple sclerosis: Diagnostic usefulness of cerebrospinal fluidAnnals of Neurology, 1977